Corteva Raised Guidance and Still Dropped 12%. Is the Selloff Overdone?

Corteva, Inc. (CTVA) saw its stock drop nearly 12% despite beating earnings and raising its full-year outlook, primarily due to a revenue miss in its second quarter, particularly in Crop Protection. The market's anxiety also stems from the upcoming separation of the company into New Corteva and Vylor, although management significantly reduced the estimated separation dissynergies. While valuation models suggest a potential upside of 29% for the stock, the performance of the third quarter, especially regarding crop protection pricing, will be crucial in validating the raised guidance and investor confidence.